Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergocalciferol supplementation to prevent peritonitis in peritoneal dialysis patients
TCTR20191109001Not yet recruiting
- Sponsor
- Kalasin Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vitamin d in end-stage kidney disease (ESKD), chronic kidney disease (CKD) and peritonitis (2 arms), sponsored by Kalasin Hospital. Primary endpoint: Incidence of peritonitis. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
end-stage kidney disease (ESKD)chronic kidney disease (CKD)peritonitis
Beyond the preview
Go deeper on TCTR20191109001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191109001.